ATE181231T1 - Verfahren zur hautpflege und mittel - Google Patents

Verfahren zur hautpflege und mittel

Info

Publication number
ATE181231T1
ATE181231T1 AT93907954T AT93907954T ATE181231T1 AT E181231 T1 ATE181231 T1 AT E181231T1 AT 93907954 T AT93907954 T AT 93907954T AT 93907954 T AT93907954 T AT 93907954T AT E181231 T1 ATE181231 T1 AT E181231T1
Authority
AT
Austria
Prior art keywords
skin care
composition
component
skin
application
Prior art date
Application number
AT93907954T
Other languages
English (en)
Inventor
Anthony Vincent Rawlings
Ian Richard Scott
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE181231T1 publication Critical patent/ATE181231T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93907954T 1992-04-02 1993-03-31 Verfahren zur hautpflege und mittel ATE181231T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207280A GB9207280D0 (en) 1992-04-02 1992-04-02 Skin care method and composition

Publications (1)

Publication Number Publication Date
ATE181231T1 true ATE181231T1 (de) 1999-07-15

Family

ID=10713365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93907954T ATE181231T1 (de) 1992-04-02 1993-03-31 Verfahren zur hautpflege und mittel

Country Status (14)

Country Link
US (1) US5439935A (de)
EP (1) EP0633764B1 (de)
JP (1) JPH07505383A (de)
KR (1) KR950700722A (de)
AT (1) ATE181231T1 (de)
AU (1) AU675426B2 (de)
BR (1) BR9306178A (de)
CA (1) CA2133085A1 (de)
DE (1) DE69325366T2 (de)
ES (1) ES2132227T3 (de)
GB (1) GB9207280D0 (de)
GR (1) GR3031016T3 (de)
WO (1) WO1993019731A1 (de)
ZA (1) ZA932403B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207288D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
US20060134641A1 (en) * 1992-05-22 2006-06-22 Franklin Richard L Treating viral infections with krill enzymes
US5958406A (en) * 1994-11-22 1999-09-28 Phairson Medical Inc. Acne treatment with multifunctional enzyme
US6030612A (en) * 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
US7947270B2 (en) * 1992-05-22 2011-05-24 Arcimboldo Ab Removing dental plaque with krill enzymes
US5945102A (en) * 1994-11-22 1999-08-31 Phairson Medical Inc. Crustacean and fish derived multifunctional enzyme
IT1270951B (it) * 1993-06-07 1997-05-26 Boehringer Mannheim Italia Metodo e dispositivo per il rilevamento simultano di neisseria gonorrhoeae, chlamydia trachomatis e mycoplasma
NZ273329A (en) * 1993-09-15 1996-09-25 Unilever Plc Skin care preparation containing stratum corneum trypsin-like enzymes
GB9319103D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
FR2721210B1 (fr) * 1994-06-17 1996-08-02 Oreal Composition de nettoyage contenant des grains lipidiques.
FR2725898B1 (fr) * 1994-10-24 1996-12-13 Oreal Produit pour application topique contenant une lipase et un precurseur d'hydroxyacide
FR2729079A1 (fr) * 1995-01-09 1996-07-12 Sederma Sa Nouvelles compositions cosmetiques contenant des ceramides et autres lipides complexes
US6232088B1 (en) 1995-02-08 2001-05-15 Phairson Medical, Inc. Treatment and prevention of immune rejection reactions
FR2732593B1 (fr) * 1995-04-04 1997-05-23 Bieurope Compositions cosmetiques a base d'enzymes proteases ou beta-glucosidases immobilisees pour favoriser l'elimination des cellules superficielles de la peau
DE19600480A1 (de) * 1996-01-09 1997-07-10 Beiersdorf Ag Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen
US6407056B1 (en) * 1996-07-12 2002-06-18 Johnson & Johnson Consumer Companies, Inc. Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor
US5776461A (en) * 1996-07-26 1998-07-07 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing phytovitamin D
DE19649098A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Proteasen
DE19649097A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Lipasen
DE19649096A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Glycosidasen
US5811112A (en) * 1997-05-30 1998-09-22 Chesebrough-Pond's Usa Co., Division Of Conopco Inc. Oil-in-water cosmetic emulsions containing a stabilized protease
US6284246B1 (en) 1997-07-30 2001-09-04 The Procter & Gamble Co. Modified polypeptides with high activity and reduced allergenicity
BR9909130A (pt) 1998-03-26 2000-12-19 Procter & Gamble Variantes de protease de serina tendo substituições de amino-ácido
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6495136B1 (en) 1998-03-26 2002-12-17 The Procter & Gamble Company Proteases having modified amino acid sequences conjugated to addition moieties
DE19824073A1 (de) * 1998-05-29 1999-12-02 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem wirksamen Gehalt an immobilisierten oder freien Lipasen, die die Viskosität von Hautfett beeinflussen
DE19829789A1 (de) * 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
US6217852B1 (en) 1998-08-15 2001-04-17 Skinnovative Dermatologic Concepts, L.L.C. Personal cleansing compositions having photoprotective agents
WO2001007578A2 (en) 1999-07-22 2001-02-01 The Procter & Gamble Company Subtilisin protease variants having amino acid substitutions in defined epitope regions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
MXPA02000842A (es) 1999-07-22 2002-07-30 Procter & Gamble Conjugados de proteasa que tienen sitios de corte protegidos estericamente.
JP2003505067A (ja) 1999-07-22 2003-02-12 ザ、プロクター、エンド、ギャンブル、カンパニー 特定のエピトープ領域にアミノ酸欠失及び置換を有するサブチリシンプロテアーゼの変異体
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6534300B1 (en) * 1999-09-14 2003-03-18 Genzyme Glycobiology Research Institute, Inc. Methods for producing highly phosphorylated lysosomal hydrolases
US6632429B1 (en) * 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
DE10025720C2 (de) * 2000-05-25 2002-05-29 Walterscheid Gmbh Gkn Antriebsanordnung mit Freilaufkupplung
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
CN1468087A (zh) * 2000-09-13 2004-01-14 宝洁公司 处理皮肤和/或头发的美容方法
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
CN100346767C (zh) * 2001-06-29 2007-11-07 株式会社资生堂 复合粉体及配合复合粉体的皮肤外用剂
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6905856B2 (en) 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US6835385B2 (en) * 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
DE10237317B4 (de) * 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
EP1600141B1 (de) * 2004-05-24 2013-04-17 3M Deutschland GmbH Zusammensetzungen mit kollagenolytisch aktivem Enzym zur Behandlung von Karies
MX2007011486A (es) * 2005-03-24 2007-11-20 Anacor Pharmaceuticals Inc Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.
EP1754464A1 (de) * 2005-08-17 2007-02-21 3M Innovative Properties Company Enzym-haltige Zusammensetzung für den dentalen Gebrauch
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
EP2217266A2 (de) * 2007-11-06 2010-08-18 Kristian Hellgren Verfahren zur behandlung von erkrankungen der mundhöhle mit einer krillenzym-zusammensetzung
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
JP5684725B2 (ja) 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
CA2747703C (en) 2009-01-06 2021-06-15 Curemark Llc Compositions and methods for the treatment or the prevention of infections by e. coli
EP2226382A1 (de) 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease zur Wundbehandlung und Hautpflege
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
CA2782622C (en) * 2009-12-08 2018-05-22 Healthpoint, Ltd. Enzymatic wound debriding compositions with enhanced enzymatic activity
DK2701733T3 (da) 2011-04-21 2019-05-27 Curemark Llc Forbindelser til behandling af neuropsykiatriske forstyrrelser
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
MX2022004048A (es) * 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
US20230233437A1 (en) * 2020-05-25 2023-07-27 Shizuoka Prefectural University Corporation Elastin production promoter and cosmetic preparation for skin
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5132M (de) * 1966-01-20 1967-06-05
FR1548652A (de) * 1967-10-27 1968-12-06
WO1984002846A1 (en) * 1983-01-21 1984-08-02 Advanced Drug Tech Enzyme ointment
EP0425016B1 (de) * 1989-10-27 1995-12-20 The Procter & Gamble Company Antimikrobielles Verfahren und Formulierung unter Verwendung von Endoglycosidase vom Typ II und antimikrobielles Mittel
US5238843A (en) * 1989-10-27 1993-08-24 Genencor International, Inc. Method for cleaning a surface on which is bound a glycoside-containing substance

Also Published As

Publication number Publication date
DE69325366D1 (de) 1999-07-22
EP0633764B1 (de) 1999-06-16
BR9306178A (pt) 1998-06-23
EP0633764A1 (de) 1995-01-18
WO1993019731A1 (en) 1993-10-14
DE69325366T2 (de) 1999-11-04
CA2133085A1 (en) 1993-10-14
AU675426B2 (en) 1997-02-06
AU3896193A (en) 1993-11-08
KR950700722A (ko) 1995-02-20
GB9207280D0 (en) 1992-05-13
GR3031016T3 (en) 1999-12-31
JPH07505383A (ja) 1995-06-15
ZA932403B (en) 1994-10-02
ES2132227T3 (es) 1999-08-16
US5439935A (en) 1995-08-08

Similar Documents

Publication Publication Date Title
DE69325366D1 (de) Verfahren zur hautpflege und mittel
KR950700720A (ko) 피부 보호 방법 및 그 조성물(Skin Care Method and Composition)
DE69500135D1 (de) Kosmetisches und/oder dermatologisches Mittel enthaltend Thermal- oder Mineralwasser und einen gegen Akne oder Älterung aktiven Agentsien
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
ATE137665T1 (de) Kosmetisches mittel
AU674142B2 (en) Use of cosmetic composition
DE3683333D1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE183075T1 (de) Retinoid enthaltendes mittel
GR3026086T3 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ATE141154T1 (de) Verfahren zur verminderung der reizenden eigenschaften von kosmetischen zusammensetzungen
ATE204455T1 (de) Topisches antibakterielles mittel
GB2347625A (en) Agent for treating allergic or hypersensivity condition
ATE215810T1 (de) Abschuppungs-zusammensetzung
FR2782922B1 (fr) Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
ATE120959T1 (de) Wasserlösliche vitamin a-zubereitungen und deren verwendung bei der hautbehandlung.
DE59803222D1 (de) Kosmetische mittel
RU94037474A (ru) Косметический крем
SE9002447L (sv) Foer hudlotioner, hudkraemer o.l. avsett koncentrat
ATE46083T1 (de) Arzneimittel zur topischen anwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties